Press Release HONEYWELL TECHNOLOGIES TO RELEASE SECOND QUARTER FINANCIAL RESULTS, DISCUSS 2026 OUTLOOK AND HOLD ITS INVESTOR CONFERENCE CALL ON THURSDAY, JULY 23
Press Release Biohaven Advances a New Class of Precision Immunology Therapies: First MoDE Extracellular Protein Degrader, BHV-1300, Begins Phase 3 Pivotal Trial in Graves’ Disease
Press Release Coppin State University Lowers Costs for Residential Students Amid Rising Higher Education Expenses
Press Release Global M&A momentum builds in 2026 as megadeals surge, but acquirers confront a new AI “winner’s paradox”–Bain & Company M&A Midyear Report
Press Release Antier Sets a New Global Standard for Blockchain Development – Every Layer, Every Industry, One Partner
Press Release Honeywell Aerospace completes spin-off from Honeywell Technologies and begins trading on Nasdaq
Press Release REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
